Arimidex 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. The Arimidex tablet is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.
The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.
If you are allergic to Anastrozole or its ingredients, tell your doctor before starting treatment with this medication. Tell your doctor if you are still experiencing menstruation and have not yet reached menopause, have osteoporosis, or have any liver or kidney problems. If you are lactose intolerant, consult your doctor before taking this medicine. Do not take medicine if you are pregnant or breastfeeding.
Arimidex 1mg side effects of medicineSeek medical attention right away if you experience any side effects. The most common side effects of Anastrozole are nausea, vomiting, headache, hot flashes, bone pain, stomach problems, breast pain, weight changes, and sleep problems. Call your doctor at once if you have any bone pain, joint pain, fever, or swelling of your menstrual period.
prophesyIf you experience any unusual vaginal bleeding or bloody or black stools, consult your doctor first. You might require a dose of Anastrozole or a blood test to know how often you need to take this medication.
If you have any skin reaction, see also:nan aromatase inhibitortreatment of estrogen-containing breast cancertreatment of estrogen-sensitive cancers
anniereprenevíde Víde Vídetell your doctor and pharmacist your medical history before taking Anastrozole.
nervousness, fatigueFatigue
Seizures
If you experience any of the following symptoms, especially anorexruption, or loss of coordination, stop taking Anastrozole and call your doctor: anorexia, bulimia, bulimia nervosa, mood changes, depression, suicidal thoughts, or a history of suicide attempt
rash on top of the skinIf you experience any changes in your mood, especially if you have any, mood changes, thoughts of suicide, or a family history of breast cancer, stop taking Anastrozole and call your doctor in advance in the near future.
This medication may rarely cause more serious problems, such as a heart attack or stroke. If you experience any serious side effects, such as symptoms of a heart attack, have a very high risk of heart problems, or if you think you have been cut off from sexual activity, talk to your doctor. Anastrozole may rarely cause more serious side effects than others.
Severe allergic reactions
If you experience any of the following symptoms, especially an rash, itching, swelling, redness, blisters, or tightness in the vagina, call your doctor: anastrozole rash, severe vaginal bleeding that doesn't go away, vaginal bleeding that doesn't stop, vaginal bleeding that doesn't stop after, vaginal bleeding that doesn't go away, vaginal bleeding that doesn't stop after, vaginal bleeding that doesn't go away, vaginal discharge that doesn't get better, or yellowing of the skin or eyes. If you have new or worsening joint or stomach pain, consider discontinuing medication and talking to your doctor.
If you experience any of the following symptoms, especially an allergic reaction such as: rash, hives, itching, or difficulty breathing, call your doctor: anastrozole rash, severe vaginal bleeding that doesn't go away, vaginal bleeding that doesn't stop, vaginal bleeding that doesn't go away, vaginal bleeding that doesn't go away, vaginal bleeding that doesn't get better, vaginal yeast infections (especially when starting on new or worsening inflammatory conditions such as rheumatoid arthritis or ankylosing spondylitis), or other yeast infections (especially when starting on new or worsening inflammatory conditions such as rheumatoid arthritis or ankylosing spondylitis).
Arimidex (Anastrozole) is a medication that's widely used to treat breast cancer in women. It's one of the most common medications used to treat this cancer type, but it's also been used to reduce the risk of developing endometrial hyperplasia (a form of enlarged prostate) in men. In this article, we'll explore the benefits of Arimidex, the medication used to treat breast cancer, including how it works for reducing the risk of developing endometrial hyperplasia, and how it can help improve overall health and reduce the risk of developing a recurrence.
Arimidex is a medication that belongs to the class of drugs called 5-hydroxytryptamine (H. E. P.) (serotonin-norepinephrine) synthetases. Arimidex works bytreating depression, anxiety, and other depression symptomsby.
However, it's important to note that Arimidex isn't a cure for breast cancer, and it can only be prescribed after a thorough understanding of the individual's unique symptoms and the specific cancer they're addressing. Arimidex can be used to treat depression in depression-free women, but it also helps reduce anxiety levels in men who have had an anxiety disorderandArimidex can also be used to treat breast cancer in women who have both cancer and had both cancer and anxiety
Depression is a mental health condition characterized by a series of symptoms such as sadness, hopelessness, lagging self-esteem, low sexual desire, and otherorweakness
Endometrial hyperplasia (Endometrial Hypercancer) is a growth in the lining of the uterus that spreads and makes for a second tumor in the body
Arimidex is also used to treat a form of breast cancer that arises in the breastin men
However, it's important to note that Arimidex isn't a cure for depression, and it can only be used after a thorough understanding of the individual's unique symptoms and the specific cancer they're addressing.Arimidex can be used to treat depression in women who have both cancer and had both cancer and anxiety
Arimidex, a medication used to treat depression, can also be used to reduce the risk of developing a recurrence in a man who has had both cancer and anxiety
However, it's important to note that Arimidex can only be prescribed after a thorough understanding of the individual's unique symptoms and the specific cancer they're addressing. Arimidex can be used to treat depression in depression-free women, but it also helps reduce anxiety levels in men who have had both cancer and had both cancer and anxiety
Arimidex, also known as anastrozole, is a medication that's widely used to treat breast cancer in women. It can also be used to reduce the risk of developing a recurrence in a man who has had both cancer and anxiety
Arimidex can be used to treat depression in depression-free women, but it also helps reduce anxiety levels in men who have had both cancer and had both cancer and had both anxiety and depression
Endometrial hyperplasia (Endometrial Hypercancer) is a growth in the lining of the uterus that occursis more aggressive than other types of breast cancer
The first clinical trial of anastrozole (arimidex) was in the United States on 27 September 2018. It was a follow-up trial with 12,000 patients who completed the first 12 weeks of the trial. The aim of the trial was to establish the efficacy of anastrozole (arimidex) in the treatment of postmenopausal women with estrogen receptor-positive breast cancer. Anastrozole was not prescribed for the treatment of advanced breast cancer in the UK (n=5,812). In the first phase, patients who had received tamoxifen for five years or longer after previous breast cancer diagnosis were included. After 12 weeks, the efficacy of anastrozole (arimidex) in the treatment of postmenopausal women with estrogen receptor-positive breast cancer was evaluated in five hundred patients (1,069, 8.8%) who completed the trial. The results indicated that there was no statistically significant difference in the overall survival rate between patients treated with anastrozole (arimidex) and those treated with tamoxifen (n=7,977). The patients were followed up for five years. The median time to death was 5.3 months. A total of 2,853 patients were treated with anastrozole (arimidex) by the first 12 weeks of the study. The median number of patients treated with tamoxifen was 2.5 (range: 0-4) with the median time to death 4.2 (range: 0.2-12.5) (p<0.05). In addition, the number of patients receiving adjuvant chemotherapy was significantly higher in the anastrozole group (2.5(2) vs 2.3(3), p<0.001). The median time to the development of a recurrence was 5.7 months (range: 1-15). The patients in the anastrozole group were more likely to have received adjuvant chemotherapy compared with tamoxifen (p<0.05). Anastrozole (arimidex) was well tolerated, with no evidence of increased mortality or long-term adverse events. The median survival time was 3.9 months (range: 1-6). In the multivariate analysis, anastrozole (n=7,977) had a statistically significant association with a higher risk of death in the adjuvant chemotherapy group (adjusted hazard ratio [HR]: 1.14, p=0.03). The median time to death was 5.3 months (range: 1-9). The overall survival rate was significantly lower in the anastrozole group (HR: 0.9(0.9-0.8). The overall survival rate in patients who received anastrozole (n=7,977) was significantly lower than that in the tamoxifen group (HR: 0.6(0.5-0.7). However, the hazard ratio was not statistically different (p=0.13) and no significant difference was observed in the risk of distant recurrence (p=0.42).
Anastrozole (arimidex) was approved by the US Food and Drug Administration (FDA) on 27 September 2018. This was the third study of anastrozole in the US. The intent-to-treat population consisted of patients with a diagnosis of breast cancer who had previously been treated with tamoxifen, hormone therapy, or a combination of the two. The primary endpoint was the overall survival rate. The intent-to-treat population was defined as patients who received a combination of tamoxifen, hormone therapy, or hormone therapy alone. The patients who received anastrozole had a higher rate of relapse (p<0.01), higher risk of death (p<0.01), and longer than average time to recurrence (p<0.05). The intent-to-treat population was defined as patients who received anastrozole at an average dose of 5 mg daily for five years or more. Anastrozole was well tolerated, with no evidence of increased mortality or long-term adverse events. The median time to recurrence was 5.2 months (range: 1-13).
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
HealthylifeHealthylife represents that the packaging refers to a product that has been prescribed only in accordance with the instructions contained in the packaging or by the manufacturer's printed information. Healthylife has made no effort to ensure that the packaging refers to a product that has been prescribed only in accordance with the instructions contained in the packaging or by the manufacturer's printed information. If you have questions about the packaging, please contact the manufacturer's contact person. If you are not sure the product has been prescribed, please contact the manufacturer's printed information.
If you have questions about the product has been prescribed, please contact the manufacturer's printed information.
Stade de France Pharmacy